On average, participants treated with levacetylleucine for 12 weeks had better fSARA scores compared to when they received a placebo. The FDA has recently approved levacetylleucine (Aqneursa; IntraBio ...
In a recent study, infants of mothers with an influenza infection during pregnancy were significantly more likely to experience febrile seizures, but not epilepsy. The risk of childhood seizures is ...
The needle-free option to treat type 1 allergic reactions, including anaphylaxis, was approved for adults and children who weigh 66 lbs or more on August 9, 2024. Epinephrine nasal spray (neffy; ARS ...
With this approval, FluMist becomes the first vaccine to prevent influenza that does not need to be administered by a health care provider. Influenza Vaccine Live (FluMist; AstraZeneca) is now FDA ...
With this acceptance, the federal agency has assigned a PDUFA date of May 22, 2025 for roflumilast foam (Zoryve) 0.3%. Results from the phase 3 ARRECTOR trial, a phase 2b study, and long-term efficacy ...
In her September 2024 article, Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, highlights the potential of digital health tools to improve care for pediatric mental health, obesity, and ...
First-generation antihistamine prescriptions were linked to a 22% higher seizure risk in young children, especially those aged 6 to 24 months, according to recent findings. First-generation ...
In a recently-published study, results demonstrated that residence in low-income, low-food access neighborhoods in early life was linked to higher subsequent child body mass index (BMI) and higher ...
Adolescents exposed to multiple adversities or elevated maternal depression showed worse mental health outcomes and altered brain connectivity. Four childhood adversity profiles were identified: low, ...
Preadolescent sleep disturbances were linked to an increased risk of suicidal thoughts and behaviors in early adolescence, highlighting sleep as a key intervention target. Findings from a study ...
The FDA has granted Breakthrough Therapy Designation for oral infigratinib (BridgeBio Pharma), which is currently under development for children with achondroplasia, according to a press release from ...
The approval is indicated for adults and children aged 2 years and older, making arimoclomol (Miplyffa) the first drug approved by the FDA to treat NPC. The FDA has approved the first drug to treat ...